脓毒症合并与不合并心力衰竭患者早期静脉输液量与住院结局的关联:一项回顾性队列研究
该回顾性队列研究纳入2012至2021年急诊收入院的9613例符合Sepsis-3的成人脓毒症患者,其中心衰患者1449例次。采用倾向性评分调整的logistic回归及限制性立方样条分析早期6小时静脉输液量与住院死亡或出院转临终关怀的关系。心衰患者接受0-15 mL/kg较30-45 mL/kg的死亡或转临终关怀风险更低(OR=0.61;95%CI 0.41-0.90;p=0.01),非心衰患者无显著差异。非心衰患者输液超过15-30 mL/kg、ICU非心衰患者超过30-45 mL/kg未与结局改善相关。
要点
- 心衰合并脓毒症患者,早期6小时静脉输液0-15 mL/kg较30-45 mL/kg,住院死亡或转临终关怀风险更低(OR=0.61;95%CI 0.41-0.90;p=0.01)。
- 不合并心衰的脓毒症患者,早期6小时输液量与死亡或转临终关怀呈非线性关系,0-15 mL/kg与30-45 mL/kg相比无显著差异。
- 不合并心衰患者输液超过15-30 mL/kg未与结局改善相关;ICU收治的不合并心衰患者超过30-45 mL/kg也未与结局改善相关。
- ICU亚组分析中观察到与主分析相似的模式,部分次要结局也呈现类似趋势。
适用人群与场景
- 2012至2021年从急诊收入院的成人脓毒症患者,符合电子健康记录为基础的Sepsis-3标准,共9613例。
- 其中心力衰竭患者1449例次,心衰诊断由国际疾病分类编码确定。
- 研究场景为城市大学附属医院,包含ICU亚组分析。
诊断标准与关键阈值
- 脓毒症诊断采用电子健康记录为基础的Sepsis-3标准。
- 心力衰竭诊断依据国际疾病分类编码确定的既存诊断。
研究设计与关键结果
- 研究类型为回顾性队列研究,共纳入9613例符合Sepsis-3的成人脓毒症患者,其中心衰患者1449例次。
- 采用倾向性评分调整的logistic回归及限制性立方样条分析早期6小时静脉输液量与住院死亡或出院转临终关怀的关系,并按心衰状态分层。
- 心衰患者中,早期6小时输液0-15 mL/kg较30-45 mL/kg与更低的死亡或转临终关怀风险相关(OR=0.61;95%CI 0.41-0.90;p=0.01)。
- 不合并心衰患者中,0-15 mL/kg与30-45 mL/kg相比无显著差异。
- 不合并心衰患者输液超过15-30 mL/kg未与结局改善相关;ICU收治的不合并心衰患者超过30-45 mL/kg也未与结局改善相关。
- ICU亚组分析显示相似模式,部分次要结局(血管加压药使用、机械通气、幸存者住院时间)也呈现类似趋势。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在符合Sepsis-3的脓毒症患者中,合并与不合并心衰者的早期液体复苏可能呈现不同的潜在获益与 harm 模式。
- 作者认为,限制性立方样条分析提示应考虑液体与结局的非线性关系,并识别出可能的收益递减点:所有不合并心衰患者为15-30 mL/kg,ICU收治的不合并心衰患者为30-45 mL/kg。
- 作者认为,心衰患者接受少于15 mL/kg与更好的结局相关,提示小容量液体可能适用于部分选择性的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the relationship between early IV fluid volume and hospital outcomes, including death in-hospital or discharge to hospice, in septic patients with and without heart failure (HF).
DESIGN: A retrospective cohort study using logistic regression with restricted cubic splines to assess for nonlinear relationships between fluid volume and outcomes, stratified by HF status and adjusted for propensity to receive a given fluid volume in the first 6 hours. An ICU subgroup analysis was performed. Secondary outcomes of vasopressor use, mechanical ventilation, and length of stay in survivors were assessed.
SETTING: An urban university-based hospital.
PATIENTS: A total of 9613 adult patients were admitted from the emergency department from 2012 to 2021 that met electronic health record-based Sepsis-3 criteria. Preexisting HF diagnosis was identified by the International Classification of Diseases codes.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: There were 1449 admissions from patients with HF. The relationship between fluid volume and death or discharge to hospice was nonlinear in patients without HF, and approximately linear in patients with HF. Receiving 0-15 mL/kg in the first 6 hours was associated with lower likelihood of death or discharge to hospice compared with 30-45 mL/kg (odds ratio = 0.61; 95% CI, 0.41-0.90; p = 0.01) in HF patients, but no significant difference for non-HF patients. A similar pattern was identified in ICU admissions and some secondary outcomes. Volumes larger than 15-30 mL/kg for non-HF patients and 30-45 mL/kg for ICU-admitted non-HF patients were not associated with improved outcomes.
CONCLUSIONS: Early fluid resuscitation showed distinct patterns of potential harm and benefit between patients with and without HF who met Sepsis-3 criteria. Restricted cubic splines analysis highlighted the importance of considering nonlinear fluid outcomes relationships and identified potential points of diminishing returns (15-30 mL/kg across all patients without HF and 30-45 mL/kg when admitted to the ICU). Receiving less than 15 mL/kg was associated with better outcomes in HF patients, suggesting small volumes may be appropriate in select patients. Future studies may benefit from investigating nonlinear fluid-outcome associations and a focus on other conditions like HF.
参考来源
- Beagle AJ, Prasad PA, Hubbard CC, et al. Associations Between Volume of Early Intravenous Fluid and Hospital Outcomes in Septic Patients With and Without Heart Failure: A Retrospective Cohort Study. Crit Care Explor. 2024. PMID: 38694845. doi:10.1097/CCE.0000000000001082
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。